All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study

JIA-HORNG KAOLee Y.-J.Heo J.Ahn S.-H.Lim Y.-S.Peng C.-Y.Chang T.-T.Torbeyns A.Hughes E.Bhore R.Noviello S.2021-09-042021-09-0420161478-3223https://www.scopus.com/inward/record.uri?eid=2-s2.0-84986321423&doi=10.1111%2fliv.13128&partnerID=40&md5=c15c7ece5d17547172433d1ca9f71867https://scholars.lib.ntu.edu.tw/handle/123456789/581902[SDGs]SDG3All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL studyjournal article10.1111/liv.13128270098312-s2.0-84986321423